Cite
OP28 DPP4 INHIBITORS AND THE DEVELOPMENT OF CONGESTIVE HEART FAILURE IN PATIENTS WITH TYPE 2 DIABETES-A POPULATION-BASED COHORT STUDY.
MLA
Hung, Y. C., et al. “Op28 Dpp4 Inhibitors and the Development of Congestive Heart Failure in Patients with Type 2 Diabetes-A Population-Based Cohort Study.” Diabetes Research & Clinical Practice, vol. 106, Nov. 2014, p. S14. EBSCOhost, https://doi.org/10.1016/S0168-8227(14)70234-7.
APA
Hung, Y.-C., Lin, C.-C., Chang, M.-P., Huang, K.-C., Wang, T.-Y., & Chen, C.-C. (2014). Op28 Dpp4 Inhibitors and the Development of Congestive Heart Failure in Patients with Type 2 Diabetes-A Population-Based Cohort Study. Diabetes Research & Clinical Practice, 106, S14. https://doi.org/10.1016/S0168-8227(14)70234-7
Chicago
Hung, Y.-C., C.-C. Lin, M.-P. Chang, K.-C. Huang, T.-Y. Wang, and C.-C. Chen. 2014. “Op28 Dpp4 Inhibitors and the Development of Congestive Heart Failure in Patients with Type 2 Diabetes-A Population-Based Cohort Study.” Diabetes Research & Clinical Practice 106 (November): S14. doi:10.1016/S0168-8227(14)70234-7.